Spotlight on Peripheral Artery Disease And Assessing Leg Pain
September 24, 2020 13:21 ET | Society for Vascular Surgery
Rosemont, Il., Sept. 24, 2020 (GLOBE NEWSWIRE) -- It is natural to experience growing aches and pains with age – a tightness in your lower back after standing for long periods of time, a crick in...
Endonovo Therapeutics Reports Third Quarter 2019 Results
November 19, 2019 16:35 ET | Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Cabot Microelectronics Corporation Logo
Cabot Microelectronics Corporation to Participate in Société de Chimie Industrielle Monthly Luncheon
October 28, 2019 19:00 ET | Cabot Microelectronics Corporation
Aurora, IL, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Cabot Microelectronics Corporation (Nasdaq: CCMP), a leading global supplier of consumable materials to semiconductor manufacturers and pipeline...
Sorrento Therapeutics Expands Resiniferatoxin (RTX) Clinical Development Program to Life-Threatening Cardiovascular Diseases With Completion of Major Animal Toxicology Study
April 15, 2019 04:00 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that its Neuro-Therapeutics unit is pursuing clinical development of resiniferatoxin...
Avinger Inc. Logo
Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study
December 19, 2018 06:00 ET | Avinger, Inc.
OCT Imaging with Pantheris Superior or Equivalent to IVUS on all Parameters REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative...
ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update
August 09, 2018 16:15 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting
November 16, 2017 08:30 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
John Marshall Law School Fraternity Honored, Named 3rd Best in Country
January 27, 2016 12:39 ET | The John Marshall Law School-Chicago
CHICAGO, Jan. 27, 2016 (GLOBE NEWSWIRE) -- The chapter of Phi Alpha Delta (PAD) Law Fraternity at The John Marshall Law School in Chicago recently was named among the top law school fraternities in...
Holy Name Medical Center First in the Northeast to Offer Magellan(TM) Robotic System
November 19, 2015 06:11 ET | Holy Name Medical Center
TEANECK, N.J., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Physicians at Holy Name Medical Center are the first in the Northeast to use the Magellan™ Robotic System, which enables them to perform complex,...
American Heart Association Logo
New Platelet Blocker Reduces Blood Clots, Artery-Opening Procedures
June 20, 2012 13:00 ET | American Heart Association
Study Highlights: An investigational platelet-blocking drug reduced the rate of dangerous blood clots in the legs and the need for artery-opening surgery in people with peripheral artery...